14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.71 $3.40 Friday, 3rd May 2024 ESPR stock ended at $2.08. This is 0.97% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.60% from a day low at $2.04 to a day high of $2.21.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Aug 26, 2021 $13.62 $14.06 $13.12 $13.21 415 775
Aug 25, 2021 $13.61 $13.84 $13.28 $13.65 283 335
Aug 24, 2021 $13.82 $14.00 $13.41 $13.60 267 620
Aug 23, 2021 $13.42 $14.28 $13.30 $13.81 506 842
Aug 20, 2021 $13.29 $13.58 $12.90 $13.17 468 669
Aug 19, 2021 $13.50 $13.98 $13.01 $13.14 623 789
Aug 18, 2021 $14.27 $14.42 $13.55 $13.58 426 085
Aug 17, 2021 $13.84 $14.40 $13.60 $14.26 414 973
Aug 16, 2021 $13.89 $14.35 $13.82 $13.87 463 334
Aug 13, 2021 $14.37 $14.78 $13.84 $13.91 533 412
Aug 12, 2021 $14.08 $14.56 $13.81 $14.52 521 904
Aug 11, 2021 $14.08 $14.70 $14.00 $14.08 438 357
Aug 10, 2021 $14.15 $14.15 $13.69 $14.03 500 911
Aug 09, 2021 $14.24 $14.68 $13.92 $14.03 488 161
Aug 06, 2021 $15.00 $15.05 $13.63 $14.21 854 896
Aug 05, 2021 $14.07 $15.04 $13.70 $15.00 670 320
Aug 04, 2021 $14.10 $15.09 $13.88 $14.00 724 077
Aug 03, 2021 $15.68 $15.89 $13.74 $14.27 1 422 530
Aug 02, 2021 $15.41 $15.61 $14.76 $14.99 1 042 156
Jul 30, 2021 $15.22 $15.50 $14.95 $15.39 831 217
Jul 29, 2021 $15.63 $15.99 $15.16 $15.19 604 630
Jul 28, 2021 $15.14 $15.99 $15.14 $15.58 604 245
Jul 27, 2021 $15.36 $15.55 $14.78 $15.20 1 015 369
Jul 26, 2021 $15.59 $15.98 $15.17 $15.41 537 270
Jul 23, 2021 $16.89 $17.00 $15.55 $15.60 836 517
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT